Jane C Tan, MD
Nephrology · Stanford
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 17
- 3 carriers
- Office
- 1
Offices
1 location · Stanford Health Care · 3,152 clinicians in this group
Hospitals listed: Stanford Health Care · Stanford Health Care Tri-Valley. That is not proof they admit you there this week.
Plans that list them
17 plans · 3 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Tan’s office at (650) 723-4000 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
17 of 17 plans
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| SCAN Balance (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Classic (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN MyChoice (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
California Medical Board record
Licence G85943 · Current
Licensed to practise in California · since 2000 · expires 2028-04-30 · University of Rochester School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
2 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend itOverall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
- Stanford Health Care Tri-ValleyPleasanton, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Stanford Health Care, which runs 3 hospitalsPatients rate it 3 of 5 · 74% would definitely recommend itOverall rating: 5 of 5 starsBetter than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.178, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.237, Oct 2024 – Sep 2025
See every measure and the patient survey for Stanford Health Care
Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 5.31 (4.24 to 6.37) · 8,661 cases | Worse | Jul 2022 – Jun 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 14.1 (12.7 to 15.7) · 2,191 cases | Worse | Jan 2024 – Dec 2024 |
| Postoperative respiratory failure rateComplications and deaths | 4.08 (1.95 to 6.21) · 5,296 cases | Better | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.317 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.446 | Better | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.241 | Better | Oct 2024 – Sep 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.7 (0.6 to 0.9) · 3,348 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.06 (0.45 to 1.67) · 5,374 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.86 (0.72 to 1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 166.09 (137.88 to 194.3) · 470 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.1 · 192 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.4 · 146 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 9.7 · 253 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 6.3 · 880 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 935 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.7 · 501 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.1 · 7,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.13 (0 to 0.27) · 20,799 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.14 to 0.43) · 23,182 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 0.94 (0.2 to 1.68) · 5,694 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.36 (1.54 to 3.19) · 7,846 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.2 (3.76 to 6.64) · 5,603 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.38 (0.23 to 2.53) · 2,211 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.52 (0.21 to 0.83) · 19,915 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.6 · 416 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.869 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.857 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.368 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 16.2 · 247 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.5 · 1,021 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 47.8 · 258 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -1.6 · 990 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 20.8 · 976 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.5 · 959 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (4.4 to 6.2) · 2,191 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.1 · 425 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.6 · 158 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 183 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.7 (10.4 to 15.4) · 4,578 cases | No different | Jan 2022 – Dec 2024 |
What patients said (6,810 patients answered, 25% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 82% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 63% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 89% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 79% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 83% |
| Staff "always" explained possible side effects | 50% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
See every measure and the patient survey for Stanford Health Care Tri-Valley
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 0 worse of 7 measures. Readmissions: 2 better, 7 the same, 0 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.178 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.237 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.79 (0 to 1.73) · 1,041 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.79 (0.5 to 1.08) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 145.81 (96.5 to 195.12) · 72 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.9 · 55 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 8.6 · 92 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 12.5 · 96 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.5 · 395 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 391 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.1 · 162 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3 · 1,736 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.16 (0 to 0.37) · 4,425 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.22 (0.02 to 0.41) · 4,771 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.45 (1.46 to 5.44) · 1,403 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.5 (0.05 to 2.94) · 645 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 1.81 (0.38 to 3.24) · 1,279 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 8.53 (3.2 to 13.85) · 639 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.15 (1.89 to 8.41) · 648 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.61 (0.14 to 3.07) · 370 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.16 (0 to 0.83) · 4,160 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4 · 74 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.369 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 1.112 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 13.1 · 110 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.1 · 437 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -5.8 · 94 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -19.3 · 456 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -0.3 · 402 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 15.8 · 358 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 6.8 (4.7 to 9.6) · 198 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 10.1 (7.5 to 13.6) · 198 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.3 · 80 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.9 · 46 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.3 · 92 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.4 (9.6 to 16.2) · 1,532 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.8 to 1.2) · 929 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,268 patients answered, 26% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 4 |
| Room was "always" clean | 65% |
| Nurses "always" communicated well | 77% |
| Doctors "always" communicated well | 79% |
| Staff "always" explained | 58% |
| Yes, staff "did" give patients this information | 88% |
| Yes, staff "did" give patients information about help after discharge | 88% |
| Doctors "always" explained things so they could understand | 74% |
| Doctors "always" listened carefully | 78% |
| Doctors "always" treated them with courtesy and respect | 86% |
| Patients who gave a rating of "9" or "10" (high) | 70% |
| Staff "always" explained new medications | 72% |
| Nurses "always" explained things so they could understand | 73% |
| Nurses "always" listened carefully | 74% |
| Nurses "always" treated them with courtesy and respect | 84% |
| "Always" quiet at night | 42% |
| "YES", patients would definitely recommend the hospital | 74% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 89% |
Original Medicare doctor bills
$24,612
Medicare paid this office $24,612 for 145 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 49 | $8,251 | $69 |
| Return visit (30+ min) | 46 | $4,166 | $79 |
| Hemodialysis procedure with physician evaluation | 28 | $3,909 | $60 |
| Long return visit (40+ min) | 11 | $1,422 | $129 |
Who their Medicare patients are
145 Original Medicare patients in 2024. Average age 65 · Under 65 36% · Women 48% · Also on Medicaid 49% · Health risk score 5.40. Above the middle of the specialty; the typical nephrology clinician is at 4.01.
Conditions among them: High blood pressure 75% · Chronic kidney disease 75% · Diabetes 54% · Heart failure 43% · Coronary heart disease 40% · Depression 26% · Atrial fibrillation 25% · Dementia 21% · Stroke 17% · Cancer 15% · COPD 11%.
The office billed $138,630, Medicare allowed $32,332 and paid $24,612; for 327 services of 15 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 145 | 327 | 65 | 5.40 | $138,630 | $24,612 |
| 2023 | 143 | 393 | 66 | 5.47 | $143,326 | $30,134 |
| 2022 | 186 | 475 | 61 | 4.74 | $164,998 | $36,044 |
| 2021 | 182 | 398 | 63 | 5.30 | $171,073 | $30,900 |
| 2020 | 153 | 276 | 65 | 4.67 | $109,076 | $20,031 |
| 2019 | 209 | 437 | 64 | 5.07 | $148,869 | $31,007 |
| 2018 | 140 | 244 | 62 | 5.12 | $65,330 | $17,522 |
| 2017 | 233 | 624 | 63 | 4.55 | $175,467 | $44,952 |
| 2016 | 231 | 598 | 62 | 4.00 | $168,871 | $40,888 |
| 2015 | 325 | 961 | 60 | 4.25 | $245,185 | $65,251 |
| 2014 | 237 | 532 | 60 | 4.49 | $140,959 | $37,704 |
| 2013 | 170 | 352 | 59 | 4.95 | $97,097 | $24,393 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 3 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 68 | $14,614 | $71 |
| Hemodialysis procedure with physician evaluation | 25 | $4,052 | $63 |
| Return visit (30+ min) | 40 | $3,794 | $88 |
2022: 5 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 68 | $11,554 | $64 |
| Return visit (30+ min) | 68 | $7,334 | $86 |
| Hemodialysis procedure with physician evaluation | 27 | $7,062 | $66 |
| Long return visit (40+ min) | 25 | $3,168 | $127 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 12 | $1,746 | $125 |
2021: 5 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 66 | $9,889 | $65 |
| Return visit (30+ min) | 49 | $4,928 | $85 |
| Dialysis procedure including 1 evaluation | 19 | $4,253 | $82 |
| Hemodialysis procedure with physician evaluation | 25 | $3,550 | $67 |
| Long return visit (40+ min) | 17 | $2,020 | $112 |
2020: 4 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 49 | $7,321 | $65 |
| Return visit (30+ min) | 51 | $3,572 | $66 |
| Hemodialysis procedure with physician evaluation | 12 | $1,221 | $64 |
| Long return visit (40+ min) | 13 | $1,142 | $88 |
2019: 7 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 79 | $12,387 | $65 |
| Return visit (30+ min) | 63 | $4,403 | $65 |
| Dialysis procedure including 1 evaluation | 25 | $4,375 | $77 |
| Long return visit (40+ min) | 24 | $2,400 | $100 |
| Hemodialysis procedure with physician evaluation | 22 | $1,940 | $65 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 11 | $1,361 | $124 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 13 | $533 | $36 |
2018: 5 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 37 | $6,341 | $65 |
| Return visit (30+ min) | 56 | $3,461 | $61 |
| Long return visit (40+ min) | 19 | $1,895 | $100 |
| Hemodialysis procedure with physician evaluation | 18 | $1,883 | $65 |
| New patient visit (60+ min) | 12 | $1,806 | $151 |
2017: 5 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 73 | $15,742 | $65 |
| Return visit (30+ min) | 110 | $12,203 | $69 |
| Dialysis procedure including 1 evaluation | 18 | $3,988 | $75 |
| Long return visit (40+ min) | 30 | $3,754 | $94 |
| Hemodialysis procedure with physician evaluation | 28 | $3,348 | $64 |
2016: 7 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 68 | $14,532 | $64 |
| Return visit (30+ min) | 125 | $11,458 | $65 |
| Hemodialysis procedure with physician evaluation | 18 | $4,203 | $65 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 11 | $1,336 | $121 |
| Long return visit (40+ min) | 13 | $1,288 | $99 |
| Short return visit (20+ min) | 15 | $684 | $46 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 12 | $523 | $35 |
2015: 6 services
| Return visit (30+ min) | 212 | $27,649 | $66 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 95 | $22,579 | $64 |
| Dialysis procedure including 1 evaluation | 18 | $5,138 | $78 |
| Hemodialysis procedure with physician evaluation | 27 | $3,048 | $64 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 16 | $1,951 | $122 |
| Short return visit (20+ min) | 11 | $458 | $38 |
2014: 8 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 76 | $12,362 | $64 |
| Return visit (30+ min) | 113 | $12,353 | $66 |
| Dialysis procedure including 1 evaluation | 14 | $3,272 | $78 |
| New patient visit (60+ min) | 13 | $1,944 | $150 |
| Hemodialysis procedure with physician evaluation | 19 | $1,549 | $65 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 12 | $1,461 | $122 |
| Long return visit (40+ min) | 11 | $1,075 | $98 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 12 | $416 | $35 |
2013: 2 services
| Return visit (30+ min) | 96 | $10,880 | $64 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 45 | $6,044 | $62 |
Medicaid work
$4,270 in 2024
Medicaid paid $4,270 for 153 billed services this clinician did in 2024, up to 20 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 133 | $3,350 |
| Hemodialysis procedure with single evaluation by a physician or other qualified health care professional | 20 | $919 |
| 2024 | 153 | 2 | 20 | $4,270 |
| 2023 | 234 | 2 | 28 | $4,744 |
| 2022 | 259 | 3 | 21 | $6,034 |
| 2021 | 127 | 2 | 25 | $3,130 |
| 2020 | 95 | 1 | 18 | $2,392 |
| 2019 | 74 | 1 | 15 | $1,945 |
See the largest Medicaid services in earlier years
2023
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 203 | $4,384 |
| Hemodialysis procedure with single evaluation by a physician or other qualified health care professional | 31 | $360 |
2022
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 184 | $4,266 |
| Hemodialysis procedure with single evaluation by a physician or other qualified health care professional | 58 | $1,467 |
| Return visit (30+ min) | 17 | $301 |
2021
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 106 | $2,105 |
| Hemodialysis procedure with single evaluation by a physician or other qualified health care professional | 21 | $1,024 |
2020
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 95 | $2,392 |
2019
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 74 | $1,945 |
Drugs they prescribed that Part D paid
$17,203
Pharmacies billed $17,203 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 245) in 2024. At or below the middle of the specialty; the typical nephrology clinician is at 0%.
245 generic and 0 brand-name prescriptions · $17,203 in drug cost · 12 antibiotic prescriptions.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Tacrolimus | 50 | $6,617 | $132 |
| Mycophenolate Mofetil | 37 | $4,853 | $131 |
| Cinacalcet | 14 | $4,350 | $311 |
| Prednisone | 71 | $322 | $5 |
| Metoprolol | 11 | $141 | $13 |
See all 6 drugs
| Tacrolimus | 50 | $6,617 | $132 |
| Mycophenolate Mofetil | 37 | $4,853 | $131 |
| Cinacalcet | 14 | $4,350 | $311 |
| Prednisone | 71 | $322 | $5 |
| Metoprolol | 11 | $141 | $13 |
| Spironolactone | 12 | $2 | $0 |
Year by year
| 2024 | 245 | 37 | 0% (0) | 0% | $17,203 |
| 2023 | 298 | 32 | 0% (0) | None | $26,779 |
| 2022 | 315 | 47 | 0% (0) | None | $37,076 |
| 2021 | 225 | 29 | 0% (0) | 0% | $28,522 |
| 2020 | 287 | 36 | 0% (0) | None | $56,345 |
| 2019 | 272 | 32 | 0% (0) | None | $34,914 |
| 2018 | 395 | 43 | 0% (0) | 13% | $37,577 |
| 2017 | 527 | 54 | 0% (0) | 10% | $50,483 |
| 2016 | 698 | 88 | 0% (0) | None | $75,885 |
| 2015 | 645 | 89 | None | None | $72,636 |
| 2014 | 425 | 64 | 0% (0) | 14% | $51,109 |
| 2013 | 800 | 76 | None | 16% | $101,209 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 5 drugs
| Cinacalcet | 16 | $14,100 | $881 |
| Tacrolimus | 70 | $7,013 | $100 |
| Mycophenolate Mofetil | 43 | $3,501 | $81 |
| Prednisone | 96 | $608 | $6 |
| Spironolactone | 14 | $13 | $1 |
2022: 4 drugs
| Cinacalcet | 17 | $9,712 | $571 |
| Tacrolimus | 71 | $9,215 | $130 |
| Mycophenolate Mofetil | 42 | $2,696 | $64 |
| Prednisone | 71 | $657 | $9 |
2021: 5 drugs
| Tacrolimus | 61 | $10,751 | $176 |
| Cinacalcet | 13 | $6,829 | $525 |
| Mycophenolate Mofetil | 55 | $3,842 | $70 |
| Prednisone | 45 | $468 | $10 |
| Tamsulosin | 18 | $102 | $6 |
2020: 7 drugs
| Tacrolimus | 75 | $11,951 | $159 |
| Cinacalcet | 18 | $8,031 | $446 |
| Mycophenolate Mofetil | 61 | $6,565 | $108 |
| Mycophenolic Acid | 13 | $4,416 | $340 |
| Prednisone | 68 | $453 | $7 |
| Tamsulosin | 12 | $26 | $2 |
| Lisinopril | 13 | $11 | $1 |
2019: 4 drugs
| Tacrolimus | 73 | $11,254 | $154 |
| Mycophenolate Mofetil | 66 | $5,623 | $85 |
| Prednisone | 69 | $604 | $9 |
| Tamsulosin | 12 | $59 | $5 |
2018: 8 drugs
| Tacrolimus | 78 | $8,498 | $109 |
| Prograf | 24 | $6,741 | $281 |
| Mycophenolate Mofetil | 79 | $5,418 | $69 |
| Prednisone | 83 | $698 | $8 |
| Tamsulosin | 17 | $190 | $11 |
| Lisinopril | 14 | $94 | $7 |
| Furosemide | 12 | $48 | $4 |
| Losartan | 11 | $45 | $4 |
2017: 13 drugs
| Tacrolimus | 121 | $12,713 | $105 |
| Sensipar | 18 | $11,960 | $664 |
| Mycophenolate Mofetil | 102 | $6,556 | $64 |
| Prograf | 20 | $5,250 | $263 |
| Prednisone | 82 | $747 | $9 |
| Clonidine | 12 | $386 | $32 |
| Tamsulosin | 24 | $314 | $13 |
| Hydralazine | 12 | $180 | $15 |
| Metoprolol | 13 | $164 | $13 |
| Lisinopril | 16 | $73 | $5 |
| Sulfamethoxazole-Trimethoprim | 17 | $66 | $4 |
| Omeprazole | 13 | $36 | $3 |
| Famotidine | 11 | $36 | $3 |
2016: 11 drugs
| Sensipar | 52 | $36,346 | $699 |
| Tacrolimus | 142 | $14,283 | $101 |
| Mycophenolate Mofetil | 135 | $6,207 | $46 |
| Prograf | 18 | $6,094 | $339 |
| Prednisone | 99 | $649 | $7 |
| Atorvastatin | 48 | $428 | $9 |
| Tamsulosin | 20 | $283 | $14 |
| Diltiazem 24hr Cd | 17 | $279 | $16 |
| Carvedilol | 11 | $85 | $8 |
| Amlodipine Besylate | 21 | $62 | $3 |
| Glipizide | 12 | $27 | $2 |
2015: 16 drugs
| Sensipar | 35 | $33,334 | $952 |
| Valganciclovir | 12 | $8,827 | $736 |
| Prograf | 18 | $6,995 | $389 |
| Tacrolimus | 69 | $6,304 | $91 |
| Mycophenolate Mofetil | 69 | $2,905 | $42 |
| Atorvastatin | 51 | $489 | $10 |
| Prednisone | 61 | $327 | $5 |
| Diltiazem 24hr Cd | 18 | $325 | $18 |
| Calcitriol | 13 | $241 | $19 |
| Tamsulosin | 14 | $222 | $16 |
| Amlodipine Besylate | 40 | $168 | $4 |
| Metoprolol | 14 | $154 | $11 |
| Glipizide | 39 | $140 | $4 |
| Furosemide | 17 | $42 | $2 |
| Lisinopril | 14 | $30 | $2 |
| Sulfamethoxazole-Trimethoprim | 12 | $24 | $2 |
2014: 10 drugs
| Tacrolimus | 47 | $12,458 | $265 |
| Procrit | 14 | $11,837 | $846 |
| Mycophenolate Mofetil | 14 | $1,488 | $106 |
| Tamsulosin | 29 | $397 | $14 |
| Amlodipine Besylate | 48 | $244 | $5 |
| Atorvastatin | 12 | $182 | $15 |
| Famotidine | 24 | $170 | $7 |
| Clonidine | 19 | $162 | $9 |
| Prednisone | 22 | $153 | $7 |
| Sulfamethoxazole-Trimethoprim | 24 | $125 | $5 |
2013: 18 drugs
| Valcyte | 62 | $59,178 | $954 |
| Tacrolimus | 34 | $12,905 | $380 |
| Mycophenolate Mofetil | 26 | $2,376 | $91 |
| Pen Needles | 27 | $946 | $35 |
| Famotidine | 85 | $714 | $8 |
| Sulfamethoxazole-Trimethoprim | 139 | $567 | $4 |
| Omeprazole | 19 | $356 | $19 |
| Amlodipine Besylate | 39 | $340 | $9 |
| Tamsulosin | 19 | $266 | $14 |
| Atorvastatin | 11 | $249 | $23 |
| Pantoprazole | 13 | $189 | $15 |
| Metoprolol | 25 | $164 | $7 |
| Carvedilol | 11 | $121 | $11 |
| Prednisone | 17 | $117 | $7 |
| Furosemide | 19 | $107 | $6 |
| Simvastatin | 17 | $106 | $6 |
| Glipizide | 18 | $101 | $6 |
| Lisinopril | 12 | $56 | $5 |
Money from drug and device companies
$2,968 in 2025
| 2025 | 2 | 2 | $2,860 | $2,968 |
| 2021 | 1 | 1 | None | $125 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Vertex Pharmaceuticals | None | $2,860 | 1 payment
|
| Apellis Pharmaceuticals | None | $108 | 1 payment
|
See all 2 published payments
| Apellis Pharmaceuticals | Meals · 2025-11-20 | None | $108 |
| Vertex Pharmaceuticals | Consulting · 2025-10-08 | None | $2,860 |
See earlier years (2021)
2021: $125
| Ablative Solutions | None | $125 | 1 payment
|
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 76.5 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1124160155
- Licence
- CA G85943California G85943: Current · expires 2028-04-30
- Trained
- University of Rochester School of Medicine and Dentistry, 1995
- Group
- Stanford Health Care
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- No
- Medicaid ID
- CA 00G859430
- Taxonomy
- Federal specialty code 207RN0300X (207RN0300X)
- Mailing address
- 750 Welch Rd, Suite 200, Palo Alto, CA, 94304
- NPI first listed
- 2007-02-13
- NPI last updated
- 2007-07-08
This is when the NPI record was last certified, not a medical board exam.